Fundraising Fox
🦊/Companies
Sign in

InterCure Ltd.

NASDAQ: INCR

Hertzliya · 1 known investors

Find your way into InterCure Ltd.

InterCure produces, manufactures, and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use in licensed markets including Israel, the European Union, and Australia, and operates a chain of over 25 licensed pharmacies across Israel, the UK, and Austria that specialize in medical cannabis dispensing.

Biotech

Founders & leadership

BCBarak Cohen
Barak CoheninBarak Cohen has over 20 years of management experience, with more than 7 years in the medical cannabis and pharmaceutical sector. He currently serves as CEO of an InterCure subsidiary overseeing medical cannabis distribution operations and trading houses across multiple departments.
AR
Alexander RabinovichNamed on SEC filing
DS
David SaltonNamed on SEC filing
LM
Lennie Michelson GrinbaumNamed on SEC filing
GH
Gideon HirschfeldNamed on SEC filing
AC
Amos CohenChief Financial Officer

Investors · 1

Nippon Venture CapitalTokyo · $1.5M – $269M

Reported raises · per SEC filings

Form D private placements
▶Undisclosed amountofferedAug 2026 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander RabinovichExecutive Officer, Director
  • David SaltonDirector
  • Lennie Michelson GrinbaumDirector
  • Gideon HirschfeldDirector
  • Amos CohenExecutive Officer
First sale
Jun 2026
Incorporated
Corporation, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

InterCure Secures NIS 22 Million Private Placement With Potential to Rise to NIS 54 Million for Global Expansion | Quiver Quantitativequiverquant.com · Jun 2026InterCure to raise NIS 22 million in private placement | INCR SEC Filing - Form 6-Kstocktitan.net · Jun 2026InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facilityfinance.yahoo.com · Dec 2024InterCure Secures $29.8M Recovery Funding Package to Rebuild War-Damaged Cannabis Facility | INCR Stock Newsstocktitan.net · Dec 2024

Frequently asked questions

What does InterCure Ltd. do?
InterCure produces, manufactures, and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use in licensed markets including Israel, the European Union, and Australia, and operates a chain of over 25 licensed pharmacies across Israel, the UK, and Austria that specialize in medical cannabis dispensing.
Who are InterCure Ltd.'s investors?
InterCure Ltd.'s investors include Nippon Venture Capital.
Where is InterCure Ltd. headquartered?
InterCure Ltd. is headquartered in Hertzliya.